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One titrimetric and two spectrophotometric methods are described for the determination of ketotifen fumarate (KTF) in bulk drug
and in tablets using cerium(IV) as the oxidimetric agent. In titrimetry (method A), the drug was treated with a measured excess
of cerium(IV) in H
2
SO
4
medium and after a standing time of 10 min, the surplus oxidant was determined by back titration with
iron(II).The spectrophotometric procedures involve addition of a known excess of cerium(IV) to KTF in acid medium followed by
the determination of unreacted oxidant by reacting with either p-dimethyl amino benzaldehyde andmeasuring the resulting colour
at 460 nm (method B) or o-dianisidine and subsequent measurement of the absorbance of coloured product at 470 nm (method C).
Titrimetric assay is based on a 1 : 2 reaction stoichiometry between KTF and cerium(IV) and the method is applicable over 2–18mg
range. In spectrophotometry, regression analysis of Beer’s law plots showed a good correlation in 0.4–8.0 and 0.4–10.0 gmL−1 KTF
ranges formethod B andmethod C, respectively, and the correspondingmolar absorptivity coefficients are calculated to be 4.0×104
and 3.7 × 104 Lmol−1 cm−1.
1. Introduction
Ketotifen fumarate (KTF) (Figure 1), chemically known
as 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10H-
benzo[4, 5]cyclohepta-[1,2-b] thiophen-10-one, which be-
longs to the group of cyclohepta thiophenones is an
antiallergic drug with stabilizing action on mast cells,
analogous to that of sodium cromoglycate, and anti-H
1
effect
[1]. Ketotifen is given orally as fumarate in the prophylactic
management of asthma and is used in the treatment of
allergic conditions such as rhinitis and conjunctivitis [2].
Ketotifen is a nonbronchodilator, antiallergic properties, and
has a specific anti-H
1
effect [3].
The drug is official in British Pharmacopoeia [4], which
describes a potentiometric titration with perchloric acid
in acetic anhydride-acetic acid medium. The therapeutic
importance of the drug has prompted the development of
a variety of techniques for its assay in pharmaceuticals and
body fluids. In pharmaceuticals, it is quantified by high per-
formance liquid chromatography [4–10], high performance
thin layer chromatography [11], liquid chromatography with
tandem mass spectrometry [12], capillary electrophoresis
[13], spectrofluorimetry [14], direct differential pulse polaro-
graphic and adsorptive-stripping voltammetry [15], and UV
spectrophotometry [16, 17]. Potentiometric titrationmethods
employing polymeric membrane sensors were also devel-
oped, where the method involved potentiometric titration of
the drug with sodium tetraphenylborate [18, 19]. Determina-
tion ofKTFhas also been carried out based on chemilumines-
cence [20–22]. Coulometric titration of KTF in pure drug and
in tablet forms using biamperometric end-point detection
was developed by Ciesilski et al. [23].
To the best of our knowledge, no visual titrimetric
method has ever been reported for KTF. Visual titrimetry and
visible spectrophotometry may serve as a useful alternatives
to many of the aforesaid sophisticated techniques because
of their cost-effectiveness, ease of operation, sensitivity, fair
accuracy, precision, and wide applicability.
Several visible spectrophotometric methods based on
colour reactions involving the amino or thiophene of the
2 International Journal of Analytical Chemistry
O
S
N
HO OH
O
O
CH3
Figure 1: Structure of KTF.
ketotifen molecule can be found in the literature. El-Kousy
and Bebawy [24] have developed three methods for the
assay of KTF in bulk drug and in tablets; the first method
was based on extraction of drug-cobalt thiocyanate ternary
complex with methylene chloride and estimation by indirect
atomic absorption method via the determination of the
cobalt content in the complex after extraction in 0.1M
hydrochloric acid at 240.7 nm. The second method is based
on the formation of orange red ion pair by the reaction of
KTF and molybdenum thiocyanate with absorption maxima
at 469.5 nm in dichloromethane. The third method was a
charge transfer reaction between drug and 2,3-dichloro-
5,6-dicyano-p-benzoquinone in acetonitrile medium. Sastry
and Naidu [25] have determined the drug in tablets and
syrup based on the reduction of Folin-Ciocalteau reagent
to a blue coloured chromogen measurable at 720 nm, in
the same article; KTF was treated with a measured excess
of N-bromosuccinimide (NBS), the unreacted oxidant was
reacted with celestine blue, and the change in absorbance
was measured at 540 nm.The third method was based on the
formation of colored species by the coupling of the diazotized
sulphanilamide, and absorbance of the colored species was
measured at 520 nm.
There are three reports on the use of ion-pair reaction for
the assay of KTF. An extractive spectrophotometric proce-
dure was based ion-pair reaction using Azocarmine G as ion-
pair reagent at pH 1.5. The ion-pair complex extracted into
CHCl
3
was measured at 540 nm [25]. Sane et al. [26] have
described four extractive spectrophotometric procedures
based on this reaction using bromophenol blue, bromoth-
ymol green, bromothymol blue and bromocresol purple,
as ion-pair reagents in acidic medium. The drug has also
been determined spectrophotometrically based on ion-pair
complex formation with bromocresol green [27] at pH 3.0
followed by extraction into chloroform and measurement at
423 nm. Beer’s law is obeyed over the concentration range
5.15–61.91𝜇gmL−1 KTF.The charge-transfer reaction of KTF
with picric acid was developed by Vachek [28]. The method
involves extraction of the picric acid-drug complex into
chloroform and measurement of the extract at 405 nm.
The reported spectrophotometric methods suffer from
some other disadvantage such as narrow linear range, poor
sensitivity, dependence on critical experimental variables,
tedious and time-consuming extraction steps, heating step,
and/or use of expensive reagent or large amounts of organic
solvents as indicated in Table 1.
From the foregoing paragraphs, it is clear that cerium(IV)
despite its strong oxidizing power, versatility, and high stabil-
ity in solution has not been applied for the assay of ketotifen.
This paper describes for the first time the application of
acidic cerium(IV) to the titrimetric and spectrophotometric
determination of KTF using p-dimethyl amino benzaldehyde
and o-dianisidine as chromogenic agents. cerium(IV) has
earlier been widely applied for the assay of a variety of
pharmaceuticals [29–33].
2. Experimental
2.1. Apparatus. A Systronics model 106 digital spectropho-
tometer (Systronics, Ahmedabad, Gujarat, India) with 1 cm
path length matched quartz cells was used to record the
absorbance values.
2.2. Materials. All chemicals used were of analytical reagent
grade. Double distilled water was used throughout the inves-
tigation. Pharmaceutical grade KTF (99.78 percent pure) was
procured from Cipla India, Ltd., Mumbai, India, as a gift
and used as received. Asthafen-1 (Torrent pharmaceuticals,
Sikkim, India) and Ketasma-1 (Sun pharmaceuticals, Sikkim,
India) tablets were purchased from local commercial market.
2.3. Reagents and Chemicals. Cerium(IV) Sulphate
(0.005M). An approximately 0.01M solution was prepared
by dissolving about 2.52 g of the chemical Ce(SO
4
)
2
⋅4H
2
O
(Loba Chemie Pvt. Ltd., Mumbai, India) in 0.5M sulphuric
acid with the aid of heat and diluting to 250mLwith the same
acid and standardized using standard ferrous ammonium
sulphate solution (FAS) [34]. It was used for titrimetric work
and diluted to obtain working concentrations of 300 and
100 𝜇gmL−1 cerium(IV) for spectrophotometric methods B
and C, respectively, with the same solvent.
Perchloric Acid (4M). Perchloric acid (4M) was prepared by
diluting appropriate volume of commercially available acid
(70%; Merck, Mumbai, India) with water.
Sulphuric Acid (5M). A 5M sulphuric acid was prepared by
appropriate dilution of concentrated acid (98%; Sp. gr. 1.84,
Merck, Mumbai, India) with water and used in bothmethods
B and C.
Ferroin Indicator. It was prepared by dissolving 0.742 g of 1,10-
phenanthroline monohydrate in 50mL of 0.025M ferrous
sulphate solution (0.348 g of ferrous sulphate heptahydrate in
50mL water).
𝑝-Dimethylamino Benzaldehyde (𝑝-DMAB) (0.5%). An accu-
rately weighed 0.5 g of𝑝-DMAB (Merck,Mumbai, India) was
transferred to a 100mL volumetric flask and dissolved in 4M
HClO
4
and the volume was made up to the mark with the
same solvent.
𝑜-Dianisidine (ODS) (0.05%). An accurately weighed 50mg
of 𝑜-dianisidine (Merck, Mumbai, India) was transferred to
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Table 1: Comparison of the performance characteristics of the proposed methods with the existing visible spectrophotometric methods.
Serial
number Reagent(s) used Methodology
𝜆max
(nm)
Linear range
(𝜇g/mL)
(𝜀 = L/mol/cm)
Remarks Reference
1
(a) Molybdenum
thiocyanate
(b) DDQ
Methylene chloride extractable
ion-pair complex measured
469.5
588
5–37.5
10–80
Employs unstable
oxidant, narrow linear
range
[24]
2
(a) F-C reagent
(b) NBS-celestine blue
(c) Sulphanilamide
(d) Azocarmine G
Measurement of the absorbance of
blue colored chromogen
Unreacted NBS measured using
celestine blue in acid medium
Measurement of pink colored
coupled product of drug with
diazotized sulphanilamide with
drug
Chloroform extractable 1 : 1 ion-pair
complex was measured
720
540
520
540
4–28
2–12
1–10
2.5–25
Multistep, unstable
oxidant, strict pH
control, and tedious
extraction procedure
[25]
3
(a) Bromophenol blue
(b) Bromothymol green
(c) Bromothymol blue
(d) Bromocresol purple
Chloroform extractable 1 : 1 ion-pair
complex was measured — 0
Required close pH
control and narrow
linear range and
involved tedious time
consuming extraction
steps
[26]
4 Bromocresol green Chloroform extractable 1 : 1 ion-paircomplex was measured 423 5.15–61.91
Required close pH
control and narrow
linear range and
involved tedious time
consuming extraction
steps
[27]
5 Ce(IV)-𝑝-DMAB
Oxidation form of 𝑝-DMAB
measured
Oxidation form of 𝑜-dianisidine
measured
460 0.4–8.0(4.0 × 104) Simple, highly sensitive,
extraction free, and use
of stable cerium(IV)
solution
This
work
Ce(IV)-𝑜-dianisidine 470 0.4–10(3.7 × 104)
a 100mL volumetric flask and dissolved in ethanol and the
volume was made up to the mark with the same solvent.
Standard KTF Solution. A stock standard solution equivalent
to 2.0mgmL−1 KTF was prepared by dissolving 200mg of
pure drug with water in a 100mL calibrated flask. This
solution was used in the titrimetric work and a working con-
centration of 20𝜇gmL−1 was prepared by stepwise dilution
with the same acid and used in method C. For method B,
200𝜇gmL−1 KTF solution was prepared separately by dis-
solving accurately weighed 20mg of pure drug in 4MHClO
4
and diluting to volume with the same solvent in a 100mL
standard flask, and the resulting solution (200𝜇gmL−1) was
diluted to 20𝜇gmL−1 with 4MHClO
4
and used for assay.
3. Assay Procedures
3.1. Titrimetry (Method A). A 10mL aliquot of the KTF
solution containing 2–18mg of KTF was transferred into a
100mL conical flask. To this, 10mL of 0.005M cerium(IV)
sulphate was added using a pipette, and the contents were
mixed well and the flask set aside for 10min. Finally, the
unreacted oxidant was titrated with 0.005M FAS solution
using one drop of ferroin indicator. Simultaneously, a blank
titration was performed, and the amount of the drug in
the measured aliquot was calculated from the amount of
cerium(IV) reacted.
The amount of KTF in the aliquot was calculated using
the formula
Amount (mg) =
{(𝐵 − 𝑆) ×𝑀
𝑤
× 𝐶}
𝑛
, (1)
where 𝐵 = volume of FAS consumed in the blank titration,
mL. 𝑆 = volume of FAS consumed in the sample titration,
mL. 𝑀
𝑤
= relative molecular mass of KTF. 𝐶 = molar
concentration or strength of oxidant in mol L−1. 𝑛 = number
of moles of Ce(IV) reacting with each mole of KTF.
3.2. Spectrophotometry Using 𝑝-Dimethylaminobenzaldehyde
(Method B). Different aliquots (0.2, 0.5, . . . , 4mL) of stan-
dard 20𝜇gmL−1 KTF solution in 4M HClO
4
were trans-
ferred into a series of 10mL calibrated flasks by means of
a microburette and the total volume in all the flasks was
adjusted to 4mL by adding 4M HClO
4
. To each flask, 2mL
of 5MH
2
SO
4
and 1mL of 300 𝜇gmL−1 Ce(IV) solution were
added, and the content was mixed well. After a standing
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time of 10min, 1mL of 0.5% 𝑝-DMAB was added to each
flask and the volume was made up to mark with 4M HClO
4
.
After 5min, the absorbance of the each coloured product was
measured at 460 nm against water.
3.3. Spectrophotometry Using 𝑜-Dianisidine (Method C). Var-
ying aliquots (0.20, 0.5, . . . , 5.0mL) of a standard 20𝜇gmL−1
KTF solution were transferred into a series of 10mL vol-
umetric flasks using a microburette and the total volume
was brought to 5mL by adding water. To each flask, 1mL of
5M H
2
SO
4
followed by 1mL of 100𝜇gmL−1 Ce(IV) solution
were added; and the content was mixed well and kept aside
for 10min at ambient temperature. Finally, 1mL of 0.05% 𝑜-
dianisidine was added to each flask, the volume was made up
to mark with water and mixed well. The absorbance of each
solution was measured at 470 nm against water blank after
5min.
A standard graph was prepared by plotting absorbance
against concentration, and the unknown concentration was
read from the graph or computed from the regression
equation derived using Beer’s law data.
3.4. Procedure for the Analysis of Tablet. Two hundred tablets
were weighed and finely powdered. An accurately weighed
quantity of the tablet powder equivalent to 100mg KTF was
transferred into a 50mL calibrated flask and about 30mL
water. The content of the flask was shaken for 20min, and
finally the volume was completed to the mark with water.
The content was mixed well and filtered through a Whatman
No. 42 filter paper. First, 5mL portion of the filtrate was
discarded, and a suitable aliquot of the filtrate (2mgmL−1
KTF) was then subjected to titrimetric analysis (method A).
This tablet extract was diluted stepwise to get 20 𝜇gmL−1
KTF with water, used in spectrophotometry (method C),
by following the procedure described earlier. Tablet extract
equivalent to 20𝜇gmL−1 KTF was prepared separately using
4M HClO
4
and subjected to analysis in spectrophotometric
method B by following the assay procedure described earlier.
3.5. Procedure for the Analysis of Placebo Blank and Synthetic
Mixture. A placebo blank containing starch (30mg), acacia
(35mg), hydroxyl cellulose (35mg), sodium citrate (40mg),
talc (30mg), magnesium stearate (45mg), and sodium algi-
nate (35mg) was prepared by combining all components to
form a homogeneous mixture. A 50mg of the placebo blank
was accurately weighed and its solution was prepared as
described under “tablets” and then subjected to analysis by
following the general procedure.
A syntheticmixturewas prepared by adding an accurately
weighed 100mg of KTF to about 150mg of the placebo
mentioned above. The extraction procedure applied for
tablets was applied to prepare 2mgmL−1 KTF solution. This
was diluted to get 20 𝜇gmL−1 KTF solutions with respective
solvents and used in spectrophotometric methods. Three
different volumes of the resulting synthetic mixture solution
were subjected to analysis by following the respective general
procedure.
4. Results and Discussion
KTF is reported to undergo oxidation with NBS [22], and
also cerium(IV) has been used as an oxidimetric reagent for
the assay of many oxidisable drugs [29–33].The present work
is based on the oxidation of the sulphur atom of the KTF
molecule by ameasured excess of cerium(IV) in acidmedium
and the surplus oxidant was determined by either titrimetry
or spectrophotometry.
4.1. Titrimetry. KTF was found to react with Ce(IV) sulphate
in sulphuric acid medium. The titrimetric method (method
A) involves oxidation of KTF by a known excess of Ce(IV)
in sulphuric acid medium with the formation of ketotifen
sulphoxide and the unreacted oxidant was determined by
back titration with FAS. H
2
SO
4
medium was favored over
HCl andHClO
4
medium since the reactionwas found to yield
a regular stoichiometry in the concentration range studied.
Reproducible and regular stoichiometry was obtained when
0.65–1.29M H
2
SO
4
concentration was maintained. Hence,
5mL of 5M H
2
SO
4
solution in a total volume of 25mL
(1M H
2
SO
4
overall) was found to be the most suitable
concentration for the quantitative reaction between KTF and
Ce(IV). Under the optimized reaction condition, there was
found to be a definite reaction stoichiometry of 1 : 2 between
KTF and Ce(IV) within the range of 2–18mg of KTF.
4.2. Spectrophotometry. In spectrophotometry (method B),
the unreacted Ce(IV) was treated with p-DMAB in HClO
4
medium to yield formic acid and p-dimethylaminophenol,
which upon further oxidation gave the corresponding
quinoimine derivative [35], measured at 460 nm, and in
method C, the surplus oxidant was treated with o-dianisidine
in acid medium to form the orange red colour product and
measured at 470 nm.
In methods B and C, the increasing concentrations of
drug added to a fixed concentration of Ce(IV) yield decreas-
ing concentrations of Ce(IV), and this concomitant decrease
in concentration results in decreasing absorbance values of
its reaction product with p-dimethylaminobenzaldehyde in
method B and with o-dianisidine in method C.
5. Method Development
5.1. Absorption Spectra. The addition of p-DMAB to Ce(IV)
resulted in the formation of yellowish red coloured product
with maximum absorption at 460 nm against blank, and the
decrease in the absorption intensity at 460 nm, caused by the
presence of the drug, was directly proportional to the amount
of the drug reacted in method B shown in Figure 2.
InmethodC, the orange coloured product of Ce(IV) with
o-dianisidine shows maximum absorption at 470 nm against
its corresponding reagent blank as shown in Figure 3, and the
decrease in the absorption intensity at 470 nm, caused by the
presence of the drug, was directly proportional to the amount
of the drug.
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Figure 2: Absorption spectra, method B, (a, b, c, and d are
absorption spectra of blank, 2, 4, and 8, 20𝜇gmL−1 KTF, resp.).
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Figure 3: Absorption spectra, method C, (a, b, c, and d are
absorption spectra of, blank, 2, 6, and 8𝜇gmL−1 KTF, resp.).
5.2. Selection of Reaction Medium. Perchloric acid (4M)
medium was found ideal for rapid and quantitative reaction
between KTF and Ce(IV) and to obtain maximum and
constant absorbance values due to Ce(IV)-p-DMAB reaction
product at 460 nm. This may be attributed to the highest
oxidation potential of Ce(IV) in HClO
4
(𝐸
𝑜
= 1.75V) as
compared to that of Ce(IV) in H
2
SO
4
(𝐸
𝑜
= 1.44V), HNO
3
(𝐸
𝑜
= 1.61V), or HCl (𝐸
𝑜
= 1.28V) [36]. Therefore, all the
solutions (ALB, Ce(IV), and p-DMAB) were prepared in 4M
perchloric acid throughout the investigation and the same
was maintained as reaction medium in method B.
5.3. Optimization of Ce(IV) Concentration for Methods B
and C. In method B, to fix the optimum concentration of
Ce(IV), different concentrations of oxidant were reacted with
a fixed concentration of p-DMAB in HClO
4
medium and the
absorbance was measured at 460 nm. A constant and maxi-
mum absorbance resulted was 30 𝜇gmL−1 Ce(IV), and hence
different concentrations of KTF were reacted with 1mL of
300 𝜇gmL−1 Ce(IV) in HClO
4
medium before determining
the residual Ce(IV). This facilitated the optimization of the
linear dynamic range over which procedure could be applied
for the assay of KTF. In method C, 10 𝜇gmL−1 Ce(IV) gave
a constant and maximum absorbance with o-dianisidine at
470 nm, and hence 1mL of 100 𝜇gmL−1 Ce(IV) was fixed as
optimum.
5.4. Study of Reaction Time and Stability of the Coloured
Species. Under the described experimental conditions, the
reaction between KTF and Ce(IV) was complete within
10min at room temperature (28 ± 2∘C). After the addition
of p-DMAB, a standing time of 5min was necessary for the
formation of coloured product, and thereafter the absorbance
of the coloured product was stable for more than an hour in
method B.
In method C, with fixed concentrations of KTF, Ce(IV),
ODS, and acid, the absorbance was measured by different
intervals of time which showed that reaction time is five
minutes, and the coloured product is stable for 15min.
5.5. Effect of Diluent. In order to select proper solvent for
dilution, different solvents were tried.The highest absorbance
values were obtained when 4M HClO
4
was used as diluting
solvent, and substitution of 4M HClO
4
by other solvents
(methanol, water, 6M HClO
4
) resulted in decrease in the
absorbance values inmethod B. InmethodC, o-dianisidine is
prepared in ethanol and drug in water, and water as a diluent
gave maximum absorbance.
6. Method Validation
6.1. Linearity and Sensitivity. The present methods were
validated for linearity, selectivity, precision, accuracy, robust-
ness, ruggedness, and recovery. Over the range investi-
gated (2–18mg), a fixed stoichiometry of 1 : 1 [KTF : Ce(IV)]
was obtained in titrimetry which served as the basis for
calculations. In spectrophotometry, the calibration graphs
were found to be linear from 0.4–8.0𝜇gmL−1 and 0.4–
10.0 𝜇gmL−1 KTF in method B and method C, respectively,
in the inverse manner.
The calibration graphs are given by the equation
𝑌 = 𝑎 + 𝑏𝑋, (2)
(where, 𝑌 = absorbance, 𝑎 = intercept, 𝑏 = slope, and 𝑋 =
concentration in 𝜇gmL−1) obtained by the method of least
squares. Sensitivity parameters such as molar absorptivity
and Sandell’s sensitivity values and the limits of detection
(LOD) and quantification (LOQ) were calculated according
to the ICH guidelines [37] using the following formulae:
LOD = 3.3 𝑆
slope
, LOQ = 10 𝑆
slope
, (3)
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Table 2: Sensitivity and regression parameters.
Parameter Method B Method C
𝜆max, nm 460 470
Colour stability, min 60 15
Linear range, 𝜇gmL−1 0.4–8.0 0.4–10
Molar absorptivity (𝜀), Lmol−1 cm−1 4.0 × 104 3.7 × 104
Sandell sensitivity∗, 𝜇g cm−2 0.0105 0.0136
Limit of detection (LOD), 𝜇gmL−1 0.39 0.43
Limit of quantification (LOQ), 𝜇gmL−1 1.19 1.32
Regression equation, 𝑌∗∗
Intercept (𝑎) 0.8744 0.8082
Slope (𝑏) −0.0914 −0.0815
Standard deviation of 𝑎 (𝑆
𝑎
) 2.2 × 10−2 6.6 × 10−2
Standard deviation of 𝑏 (𝑆
𝑏
) 4.9 × 10−3 7.3 × 10−3
Regression coefficient (𝑟) −0.9998 −0.9990
∗Limit of determination as the weight in 𝜇g per mL of solution, which corresponds to an absorbance of 𝐴 = 0.001 measured in a cuvette of cross-sectional
area 1 cm2 and 𝑙 = 1 cm. ∗∗𝑌 = 𝑎 + 𝑏𝑋, where 𝑌 is the absorbance,𝑋 is concentration in 𝜇gmL−1, 𝑎 is intercept, and 𝑏 is slope.
Table 3: Results of intraday and interday accuracy and precision study.
Method KTF taken
mg/𝜇gmL−1
Intraday accuracy and precision (𝑛 = 7) Interday accuracy and precision (𝑛 = 7)
KTF found
mg/𝜇gmL−1 RE % RSD %
KTF found
mg/𝜇gmL−1 RE % RSD %
A
5.00 5.06 1.20 1.80 5.12 2.42 2.90
10.0 10.12 1.62 1.40 10.15 1.51 2.43
15.0 14.80 1.34 0.94 14.72 1.58 1.92
B
2.0 2.02 1.23 1.72 2.03 1.62 1.18
4.0 3.96 1.62 0.87 3.94 1.26 1.58
6.0 6.08 1.33 1.46 6.17 1.90 0.88
C
4.0 3.94 0.73 1.43 3.95 1.14 2.12
6.0 6.06 1.06 1.09 6.11 1.84 1.79
8.0 7.90 1.21 1.18 7.88 1.47 1.09
In method A, KTF taken/found, is in mg and it is 𝜇gmL−1 in method B and C.
RE: relative error (%); RSD: relative standard deviation (%).
where 𝑆 is the standard deviation of the absorbance of seven
blank readings. These are summarized in Table 2.
6.2. Accuracy and Precision. The repeatability of the pro-
posed methods was determined by performing five replicate
determinations. The intra-day and inter-day variation in the
analysis of KTF was measured at three different levels. The
accuracy of an analytical method expresses the closeness
between the reference value and the found value. Accuracy
was evaluated as percentage relative error between the mea-
sured and taken amounts/concentrations. The results of this
study are compiled in Table 3 and speak of the excellent
intermediate precision (%RSD ≤ 2.90) and accuracy (%RE ≤
2.42) of the results.
6.3. Robustness andRuggedness. To evaluate the robustness of
the methods, two important experimental variables, namely,
standing time and volume of H
2
SO
4
, were slightly varied,
and the capacity of all the methods was found to remain
unaffected by small deliberate variations. The results of this
study are presented in Table 4 and indicate that the proposed
methods are robust. Method ruggedness was demonstrated
having the analysis done by four analysts and also by a single
analyst performing analysis on four different apparatus or
instruments in the same laboratory. Intermediate precision
values (%RSD) in both instances were in the range of
0.59%–2.96% indicating acceptable ruggedness. The results
are presented in Table 4.
6.4. Selectivity. In the analysis of placebo blank, there was
no measurable consumption of Ce(IV) in titrimetry and the
same absorbance value as obtained for the reagent blank
was recorded in method B and method C, suggesting the
noninterference by the inactive ingredients added to prepare
the placebo.
In method A, 5mL of the resulting solution prepared by
using synthetic mixture was assayed titrimetrically (𝑛 = 5)
and yielded a percentage of recovery of 102.3 ± 0.62KTF. In
spectrophotometry, 2mL of 20𝜇gmL−1 KTF in method B
International Journal of Analytical Chemistry 7
Table 4: Method robustness and ruggedness expressed as intermediate precision.
Method KTF taken
mg/𝜇gmL−1
Robustness Ruggedness
H2SO4 volume, mL
(% RSD), 𝑛 = 3
Reaction time, min
(% RSD), 𝑛 = 3
Ineranalysis (% RSD),
𝑛 = 4
Intercuvettes/burettes
(% RSD), 𝑛 = 4
A
5.0 0.88 1.63 0.81 0.85
10.0 1.33 1.83 1.93 1.23
15.0 1.03 0.59 0.89 0.96
B
2.0 2.60 2.11 2.11 2.38
4.0 2.71 1.36 2.63 1.82
6.0 1.79 1.80 1.58 2.83
C
4.0 2.66 2.70 2.01 2.71
6.0 2.45 1.83 2.79 1.99
8.0 1.72 1.27 1.69 2.96
In titrimetry, standing times were 8, 10, and 12min.
In spectrometric methods B and C, reaction time, 10 ± 1min; volume of H2SO4 2 ± 0.2mL and 1 ± 0.2mL varied, respectively.
Table 5: Results of analysis of tablets by the proposed methods and statistical comparison with the reference method.
Tablets analysed Label claim,mg/tablet
Found∗ (percent of label claim ± SD)
Reference method Proposed methods
Method A Method B Method C
Asthafen 1 100.8 ± 0.91
101.4 ± 0.89 102.8 ± 1.91 102.1 ± 1.75
𝑡 = 1.05 𝑡 = 2.11 𝑡 = 2.16
𝐹 = 1.05 𝐹 = 4.41 𝐹 = 3.7
Ketasma 1 102.3 ± 1.02
100.6 ± 0.98 102.8 ± 1.36 101.3 ± 0.88
𝑡 = 2.69 𝑡 = 0.66 𝑡 = 1.66
𝐹 = 1.08 𝐹 = 1.78 𝐹 = 1.34
∗Mean value of five determinations;
Tabulated 𝑡 value at the 95% confidence level is 2.78.
Tabulated 𝐹 value at the 95% confidence level is 6.39.
and 3mL of 20𝜇gmL−1 KTF in method C when subjected to
analysis (𝑛 = 5) yielded percentage of recoveries of 98.24%
and 101.8% KTF with standard deviations of 1.74 and 2.32,
respectively. These results complement the findings of the
placebo blank analysis with respect to selectivity.
6.5. Application to Tablet Analysis. Commercial KTF tablets
were analyzed using the developed methods and also a
referencemethod [38].The referencemethod involves poten-
tiometric titration of KTF in anhydrous acetic anhydride—
acetic acid medium with acetous perchloric acid. The results
obtained were compared statistically by Student’s 𝑡-test and
the variance-ratio 𝐹-test. The calculated 𝑡 and 𝐹 values did
not exceed the tabulated values of 2.78 and 6.39 at the 95 %
confidence level and for four degrees of freedom, indicating
close similarity between the proposed methods and the
reference method with respect to accuracy and precision.
These results are summarized in Table 5.
6.6. Recovery Study. To further ascertain the accuracy and
reliability of the methods, recovery experiments were per-
formed via standard-addition procedure. Preanalysed tablet
powder was spikedwith pure KTF at three different levels and
the total was found by the proposed methods. Each deter-
mination was repeated three times. The percent recovery of
pure KTF added (Table 6) was within the permissible limits
indicating the absence of inactive ingredients in the assay.
7. Conclusions
Three methods have been developed for determination of
ketotifen fumarate in bulk drug and in its tablets and vali-
dated as per the current ICH guidelines. The present visual
titrimetricmethod is simple and economical compared to the
reported coulometric method [23]. The spectrophotometric
methods are characterized by simplicity since they do not
involve any critical experimental variable and are free from
tedious and time-consuming extraction steps and use of
organic solvents unlike many previous methods as indicated
in Table 1. The method using o-dianisidine looks more
sensitive than most existing methods. Both have additional
advantages of ease of operation and possibility of carrying
them out with a common laboratory instrument unlike
many other instrumental methods reported for ketotifen.
They are characterized by high selectivity and comparable
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Table 6: Results of recovery study via standard addition method with tablet.
Method Tablet studied KTF in tabletmg/𝜇gmL−1
Pure KTF added
mg/𝜇gmL−1
Total found
mg/𝜇gmL−1
Pure KTF∗
Percent ± SD
A Ketasma-1
6.03 3.0 9.24 102.3 ± 1.98
6.03 6.0 12.22 101.6 ± 1.25
6.03 9.0 15.29 101.3 ± 2.08
B Ketasma-1
3.03 1.5 4.54 101.1 ± 1.26
3.03 3.0 6.09 102.1 ± 1.98
3.03 4.5 7.59 101.4 ± 1.34
C Ketasma-1
2.05 1.0 3.06 101. 1 ± 1.63
2.05 2.0 4.03 99.36 ± 1.28
2.05 3.0 5.12 102.4 ± 1.53
∗mg in method A; 𝜇gmL−1 in methods B and C. ∗Mean value of three determinations.
sensitivity with respect to the existing methods. The accu-
racy, reproducibility, simplicity, and cost-effectiveness of the
methods suggest their application in the quality control
laboratories where the modern and expensive instruments
are not available.
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